DSS1 as potential prognostic marker for breast cancer progression and relapse-free patient survival

被引：0
|
作者：
Rezano, Andri [1 ,2 ]
Kuwahara, Kazuhiko [2 ]
Yamamoto-Ibusuki, Mutsuko [3 ]
Kitabatake, Masahiro [2 ]
Moolthiya, Penpak [2 ]
Phimsen, Suchada [2 ]
Suda, Taiji [4 ,5 ]
Tone, Shigenobu [4 ,5 ]
Yamamoto, Yutaka [3 ]
Iwase, Hirotaka [3 ]
Sakaguchi, Nobuo [2 ]
机构：
[1] Padjadjaran State Univ, Dept Anat & Cellular Biol, Bandung, West Java, Indonesia
[2] Kumamoto Univ, Dept Immunol, Kumamoto, Japan
[3] Kumamoto Univ, Dept Breast & Endocrine Surg, Kumamoto, Japan
[4] Kawasaki Med Sch, Dept Biochem, Kurashiki, Okayama, Japan
[5] Kawasaki Med Sch, Electron Microscope Ctr, Kurashiki, Okayama, Japan
来源：
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 2014年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
537
引用
收藏
页码：S114 / S114
页数：1
相关论文
共 50 条
  • [21] Soluble PD-L1 reflects cachexia status in patients with gastric cancer and is an independent prognostic marker for relapse-free survival after radical surgery
    Matsumoto, Yasunori
    Sasaki, Takuma
    Kano, Masayuki
    Shiraishi, Tadashi
    Suito, Hiroshi
    Murakami, Kentaro
    Toyozumi, Takeshi
    Otsuka, Ryota
    Kinoshita, Kazuya
    Iida, Shinichiro
    Morishita, Hiroki
    Nishioka, Yuri
    Hayano, Koichi
    Kurata, Yoshihiro
    Hayashi, Hideki
    Matsubara, Hisahiro
    MOLECULAR AND CLINICAL ONCOLOGY, 2023, 18 (05)
  • [22] LGR5 overexpression confers poor relapse-free survival in breast cancer patients
    Hou, Ming-Feng
    Chen, Po-Ming
    Chu, Pei-Yi
    BMC CANCER, 2018, 18
  • [23] RELAPSE-FREE SURVIVAL IN BREAST-CANCER PATIENTS - THE IMPORTANCE OF THE PRESENCE OF PROGESTERONE RECEPTORS FOR PROGNOSIS
    ZIELINSKI, CC
    KUZMITS, R
    SPONA, J
    SALZER, H
    KUBISTA, E
    STAFFEN, A
    AIGINGER, P
    BLUT, 1984, 49 (03): : 243 - 243
  • [24] LGR5 overexpression confers poor relapse-free survival in breast cancer patients
    Ming-Feng Hou
    Po-Ming Chen
    Pei-Yi Chu
    BMC Cancer, 18
  • [25] Computational metabolism modeling predicts risk of distant relapse-free survival in breast cancer patients
    Trilla-Fuertes, Lucia
    Gamez-Pozo, Angelo
    Diaz-Almiron, Mariana
    Prado-Vazquez, Guillermo
    Zapater-Moros, Andrea
    Lopez-Vacas, Rocio
    Nanni, Paolo
    Zamora, Pilar
    Espinosa, Enrique
    Fresno Vara, Juan Angel
    FUTURE ONCOLOGY, 2019, 15 (30) : 3483 - 3490
  • [26] Effect of xenon anaesthesia on relapse-free survival in treatment of breast cancer: relation with immune status
    Avdeev, S.
    Stakheeva, M.
    Odyshev, V
    Faltin, V
    Slonimskay, E.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2014, 31 : 11 - 11
  • [27] Endosomal protein expression of γ1-adaptin is associated with tumor growth activity and relapse-free survival in breast cancer
    Hoshi, Nobuhiro
    Uemura, Takefumi
    Tachibana, Kazunoshin
    Abe, Sadahiko
    Murakami-Nishimagi, Yuko
    Okano, Maiko
    Noda, Masaru
    Saito, Katsuharu
    Kono, Koji
    Ohtake, Tohru
    Waguri, Satoshi
    BREAST CANCER, 2024, 31 (02) : 305 - 316
  • [28] Hormones as indicator of relapse-free period in breast cancer (BC).
    Samaneva, Natalia Yu
    Frantsiyants, Elena M.
    Vladimirova, Liubov Yu
    Storozhakova, Anna E.
    Sheiko, Elena A.
    Bandovkina, Valeria A.
    Cheryarina, Natalia D.
    Tikhanovskaya, Natalia M.
    Kit, Oleg, I
    Lisutin, Aleksandr E.
    Shatova, Iuliana S.
    Vashchenko, Larisa N.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] Worse event-free and relapse-free survival in financially disadvantaged patients with breast cancer in South India
    Thumsi, J.
    Nataraj, M.
    Kavitha, M. L.
    Jadhav, S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S80 - S81
  • [30] Preoperative serum MMP-9 immunoreactive protein is a prognostic indicator for relapse-free survival in breast carcinoma
    Talvensaari-Mattila, A
    Turpeenniemi-Hujanen, T
    CANCER LETTERS, 2005, 217 (02) : 237 - 242
12345